← Back

ASCA and p-ANCA in children with suspected IBD

In children with suspected IBD, what is the evidence for ASCA and p-ANCA testing to differentiate UC from CD

DecisionNot yet clinician-reviewed

What is known

  • ASCA is associated with Crohn disease and p-ANCA is a recognized marker for ulcerative colitis. 1
  • Combined measurement of pANCA and ASCA has been proposed as a diagnostic approach to differentiate ulcerative colitis from Crohn disease. 2,3
  • The role of pANCA and ASCA in IBD diagnosis and differentiation is described as still imprecise and controversial. 4
  • Endoscopy, radiology and histopathology remain the basis of diagnosis, and differentiation is not possible in a minority of cases (indeterminate colitis). 5

What is unknown / caveats

  • Some sources frame combined ASCA/pANCA as a helpful diagnostic tool, while others state its role is imprecise and controversial
  • Retrieved excerpts are largely background sections and reference lists, without extractable pediatric sensitivity/specificity data
  • No excerpt directly reports the diagnostic performance of these markers specifically in children with suspected IBD
  • The excerpts establish the marker–disease associations but do not quantify how reliably combined testing differentiates the two conditions in children.

References

  1. Lecis P, Germanà B, Papa N, Bertiato G, Doglioni C, Galliani E, Biedo FC. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease]. Recenti Prog Med. 2002;93(5):308-13. PMID: 12050913.
  1. Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96(2):449-54. PMID: 11232689.
  1. Papadakis KA, Targan SR. Serologic testing in inflammatory bowel disease: its value in indeterminate colitis. Curr Gastroenterol Rep. 1999;1(6):482-5. PMID: 10980990.
  1. Mokrowiecka A, Daniel P, Słomka M, Majak P, Malecka-Panas E. Clinical utility of serological markers in inflammatory bowel disease. Hepatogastroenterology. 2009;56(89):162-6. PMID: 19453050.
  1. Montanelli A, Mainardi E, Vagni A, Villanacci V, Zambelli C, Cestari R, Cengia P, Minelli L, Missale G. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool. Minerva Gastroenterol Dietol. 2005;51(2):201-7. PMID: 15990710.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.


Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.

Reviewer notes

answered 2026-08-04 · corpus build 71e61f41 · faithfulness 0.84